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Abstract 
Dopamine signaling facilitates the attribution of incentive salience, or incentive motivational 
value, to both food- and drug-associated cues.  Understanding the neurobiological mechanisms 
by which incentive salience is attributed to reward cues may contribute to the development of 
successful treatments for addiction and related disorders. Previous work has shown that 
dopamine facilitates the development of a sign-tracking, but not a goal-tracking response. 
However, it is not yet known which receptors are critical for allowing dopamine to encode the 
incentive motivational properties of reward cues. Here I studied the impact of different 
pharmacological agents targeting dopamine D2 and D3 receptors on the expression of sign- and 
goal-tracking behaviors.  Following Pavlovian conditioned approach training rats were classified 
as sign- or goal-trackers. Rats were then treated with the D2/D3 agonist 7-OH-DPAT (0.01-0.32 
mg/kg), the D2/D3 antagonist raclopride (0.1 mg/kg), or the selective D3 antagonist SB-277011A 
(6-24 mg/kg). The effects of these agents on the expression of sign- and goal-tracking 
conditioned responses were examined. Treatment with the D2/D3 dopamine receptor agonist 7-
OH-DPAT or antagonist raclopride specifically attenuated the performance of the previously 
acquired conditioned response. Treatment with SB-277011A did not impact the expression of 
either the sign- or goal-tracking conditioned response. Although dopamine has been shown to 
encode the incentive motivational properties of reward cues, the present findings suggest that 
signaling at the dopamine D2 receptor may be critical for both the incentive and predictive 
properties of reward cues. That is, both agonism and antagonism at the dopamine D2 receptor 
affected the expression of both sign- and goal-tracking behaviors.   
Keywords: Incentive Salience, Motivation, Pavlovian conditioning, Autoshaping, Sign-tracking, 
Goal-tracking, Dopamine, D2 receptor, D3 receptor 
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Introduction 
There is general agreement in the literature that mesolimbic dopamine signaling is 
involved in reward-related processes, but its exact involvement has been controversial. Some 
have argued that dopamine encodes a reward-prediction error signal, necessary for learning cue-
reward relationships (Hollerman & Schultz, 1998; Schultz, Dayan, & Montague, 1997; Steinberg 
et al., 2013). In contrast, others have argued that mesolimbic dopamine facilitates the attribution 
of Pavlovian incentive value—or incentive salience—to reward-paired cues (Flagel et al., 2011).  
Incentive salience is the process by which neutral cues in the environment come to serve as 
predictors of reward in addition to becoming attractive and rendering cues desirable in their own 
right (Berridge & Robinson, 1998; 2003). Reward-paired stimuli in the environment that become 
attributed with incentive salience—incentive stimuli—are able to evoke a motivational drive, or 
“wanting”, that can trigger complex emotional states. Until recently, it was difficult to parse 
whether cues attain solely a predictive or also an incentive relationship with reward, because 
Pavlovian conditioned reward cues can simultaneously acquire both incentive and predictive 
value. However, there now exists an animal model that captures individual variation in the extent 
to which incentive salience is attributed to reward-paired cues, and this variation can be 
exploited to elucidate the neural mechanisms underlying stimulus-reward learning. 
Using a classical Pavlovian conditioning paradigm termed autoshaping in which 
presentation of a lever-cue predicts the delivery of a food reward in an adjacent food cup, 
individuals develop distinct conditioned responses. Some animals, termed sign-trackers (Hearst 
& Jenkins, 1974), approach and vigorously engage the lever-cue. Others, termed goal-trackers 
(Boakes, 1977), orient and then enter the food cup upon presentation of the lever-cue. Though 
both groups of animals readily learn the association between the cue and reward, and consume 
D2/D3 SIGNALING AND PAVLOVIAN CONDITIONED APPROACH 	   5 
all of the food pellets, only for sign-trackers does the cue become imbued with incentive 
salience. Thus, for sign-trackers, the cue becomes an incentive stimulus (Berridge, 2001; 
Cardinal, Parkinson, Hall, & Everitt, 2002). That is, only for sign-trackers does the cue become 
attractive to the extent that it elicits approach (Flagel, Watson, Akil, & Robinson, 2008) and 
supports the learning of an instrumental response as an effective conditioned reinforcer 
(Robinson & Flagel, 2009). 
The ability to parse the incentive from the predictive qualities of a reward cue facilitates 
the study of the psychological and neurobiological mechanisms underlying motivated behavior. 
Indeed, the neurobiology subserving the attribution of incentive salience to cues has only just 
begun to be elucidated; and thus far, the primary focus has been on the role of dopamine in these 
behaviors. Using the sign-tracker/goal-tracker animal model, Flagel and colleagues illustrated 
that non-specific systemic antagonism of dopamine with flupenthixol prevented the development 
of a sign-tracking conditioned response, thus blocking incentive salience attribution; but 
flupenthixol administration did not disrupt learning of a goal-tracking conditioned response 
(Flagel et al., 2011). Also in this study, it was demonstrated that dopamine transmission in the 
nucleus accumbens core tracked the attribution of incentive, but not predictive, value to a 
reward-paired stimulus (Flagel et al., 2011). Additionally, nonspecific antagonism of dopamine 
in the nucleus accumbens core has been shown to selectively attenuate expression of the sign-
tracking conditioned response (Saunders & Robinson, 2012). Therefore, sign-tracking is 
dependent on the actions of dopamine for both its acquisition and expression, whereas the 
development of a goal-tracking response is dopamine independent. 
While previous work has clearly demonstrated a critical role for dopamine in the 
attribution of incentive salience to reward cues, the mechanisms of these effects are not yet 
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known. The pharmacological agents that were previously used to target the dopamine system in 
this animal model were non-specific, antagonizing both dopamine D1- and D2-type receptors. 
Recent work, however, has highlighted a role of the dopamine D3 receptor in cue-motivated 
behaviors, especially those pertaining to drug self-administration (for review see Le Foll & Di 
Ciano, 2014). For example, modulation of dopamine D3 receptor function by systemic 
administration of either a dopamine D3 receptor agonist or antagonist reduces conditioned 
hyperactivity in response to cues previously associated with cocaine administration (Le Foll, 
Frances, Diaz, Schwartz, & Sokoloff, 2002). Moreover, both systemic and local injections of a 
dopamine D3 receptor antagonist into the nucleus accumbens or central nucleus of the amygdala 
attenuates the ability of cocaine-cues to produce reinstatement of cocaine seeking behavior (Xi et 
al., 2012). In addition, antagonism of dopamine D3 receptors has been shown to decrease self-
administration of psychostimulants, and abolish the ability of these substances to elicit 
conditioned place preference (Song et al., 2014; 2011; 2013).  
As the D3 receptors have become a target for the treatment of addictive behaviors, and 
the sign- and goal-tracking model has preclinical relevance (Robinson, Yager, Cogan, & 
Saunders, 2014), I sought to explore if signaling at the D2 and D3 receptors may mediate the 
performance of a sign- or goal-tracking conditioned response. In separate cohorts of animals the 
impact of the D2/D3 agonist 7-OH-DPAT and the D2/D3 antagonist raclopride on the expression 
of sign- and goal-tracking conditioned responses was examined. Then, to probe solely the role of 
D3 signaling in these behaviors, the selective D3 antagonist SB-277011A (Reavill et al., 2000) 
was administered. 
Methods 
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All experiments followed the principles of animal care published in the Guide for the 
Care and Use of Laboratory Animals: Eighth Edition, revised in 2011, published by the National 
Academy of Sciences, and all procedures were approved by the University of Michigan’s 
University Committee on the Use and Care of Animals. All rats were housed in a temperature- 
and humidity-controlled room and maintained on a 12-h light/ dark cycle (lights on at 07:00 hrs). 
After arrival at our facilities rats were given one week to acclimate before handling and 
experimental procedures began. Water and food were available ad libitum throughout the 
experiments. 
Apparatus 
Behavioral testing occurred in standard Med Associates conditioning chambers (20.5 x 
24.1 cm floor area, 29.2 cm high; St. Albans, VT) that were located in sound attenuating cabinets 
equipped with ventilating fans that served as white noise and masked outside noise. For 
Pavlovian conditioning sessions each chamber had a food cup located in the center of one wall, 
approximately 3 cm above the grid floor, and was flanked 2.5 cm on the right or left by a 
retractable lever, located 6 cm above the grid floor. The location of the lever was 
counterbalanced across rats. Levers required a 10 g force to deflect and each deflection was 
recorded as a “contact”.  Located on the opposite wall, near the top of the chamber, was a white 
house light that was illuminated for the duration of each session. Operation of the pellet 
dispenser (Med Associates) resulted in the delivery of one 45 mg banana-flavored grain food 
pellet (Bio-Serv, Frenchtown, NJ) into the food cup. 
Pavlovian Conditioned Approach 
Pavlovian training procedures were similar to those described previously (Flagel, 
Watson, Robinson, & Akil, 2007; Meyer et al., 2012). All sessions were conducted between the 
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hours of 10:00-17:00. For the 2 days prior to training, rats were handled by experimenters and 
given a small amount of 45-mg banana pellets in their home cage, to acquaint the animals with 
the food to be used as the unconditioned stimulus (US). Animals then received two sessions of 
food cup training in the conditioning chambers, for which the food cups were primed with 3 
pellets prior to session start.  Each pre-training session consisted of the delivery of 25 banana 
pellets on a variable interval (VI) 30 s schedule, averaging 12.5 minutes per session. All animals 
retrieved all of the pellets during food cup training and Pavlovian autoshaping procedures began 
the following day.  
During Pavlovian autoshaping sessions a trial consisted of insertion of the illuminated 
lever (conditioned stimulus, CS) into the chamber for 8 s at which time it was retracted and 
immediately followed by delivery of a 45-mg food pellet (unconditioned stimulus, US) into the 
adjacent food cup. Twenty-five trials occurred with an inter-trial interval (ITI) on a VI 90 s 
schedule (the period between CS presentations could range from 30 s to 150 s), and each session 
lasted approximately 40 minutes. The following were recorded per trial using Med Associates 
software: 1) number of lever contacts, 2) latency to first lever contact, 3) number of food cup 
entries during CS presentation, 4) latency to first food cup entry during CS presentation, and 5) 
number of food cup entries during the ITI. Using these metrics, sign- and goal-tracking behavior 
can be quantified to examine an individual’s preference for the lever-CS or the food cup. In 
addition, the number of food pellets consumed was recorded after each session to ensure all 
animals were consuming their pellets. 
Drugs 
(±)-7-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (7-OH-DPAT) was received 
from the National Institutes of Mental Health Chemical Synthesis and Drug Supply Program. S-
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(-)-Raclopride was purchased from Sigma-Aldrich (R121; St. Louis, MO). SB-277011A (trans-
N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide) 
was provided by Dr. Eliot Gardner (National Institute on Drug Abuse Intramural Research 
Program). 7-OH-DPAT and raclopride were dissolved in 0.9% sterile physiological saline and 
administered subcutaneously. SB-277011A was dissolved in 25% w/v hydroxypropyl-β-
cyclodextrin in sterile water and was administered intraperitoneally. All solutions were made 
fresh daily and administered in a volume of 1 ml/kg. 
Experiment 1: The Effect of D2/D3 Agonism by 7-OH-DPAT on Pavlovian Conditioned 
Approach Behaviors and Conditioned Reinforcement 
Effect of 7-OH-DPAT on Conditioned Responding 
Male Sprague-Dawley rats (n=30; Harlan Laboratories, Indianapolis, IN) weighing 250-
300 g were triple-housed upon arrival. Rats were classified as sign-trackers (STs) or goal-
trackers (GTs) based on their average Pavlovian Conditioned Approach (PCA) index score 
(Meyer et al., 2012) from sessions 6 and 7 of a 7-day Pavlovian training paradigm. This index 
score accounts for three measures of approach behavior: the difference in latency to approach the 
food cup or lever, the difference in probability between approaching the food cup or lever, and 
the ratio of contacts with the food cup vs. the lever. PCA index scores range from -1.0 to 1.0. 
Those animals with an average index ranging from -1.0 to -0.3 were classified as GTs (n=8) and 
those with an index ranging from 0.3 to 1.0 were classified as STs (n=10). On the eighth and 
ninth sessions all rats received injections of vehicle 15 minutes prior to session start. A within 
subjects design was then used to examine the effects of 7-OH-DPAT on the expression of sign- 
and goal-tracking behaviors (see Figure 1a for experimental design). Rats received escalating 
doses of 7-OH-DPAT in the following order: 0.01, 0.032, 0.1, 0.2, and 0.32 mg/kg fifteen 
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minutes prior to each session. These doses were selected to examine the effects of increased D2 
relative to D3 stimulation; and also to avoid nonspecific effects on locomotor activity (G. T. 
Collins et al., 2007; Li et al., 2010). On the days following each dose rats received vehicle 
injections to prevent carry-over drug effects. Thus, 7-OH-DPAT was administered prior to 
sessions 10,12,14,16, and 18 and vehicle was administered prior to sessions 11,13,15 and 17 and 
an additional 2 days following the last dose tested (i.e. sessions 19 and 20).  
Conditioned Reinforcement 
The day after the last Pavlovian training session (i.e. Session 20), rats were split into 
vehicle (GT n=4, ST n=5) or treatment (GT n=4, ST n=5) groups, which were counterbalanced 
based on their original index score from sessions 6 and 7. Rats in the treatment group received 
0.032 mg/kg 7-OH-DPAT. This dose was chosen for its preference for D3 over D2 receptors in 
addition to the effects observed during the expression phase of the experiment (G. T. Collins et 
al., 2007). The conditioning chambers were rearranged such that the food cup and pellet 
dispenser were removed and the retractable lever was placed in the center of the chamber, still 6 
cm above the grid floor. Two nose ports were located approximately 2.5 cm on either side of the 
lever and were located with the bottom of the port approximately 4 cm above the grid floor. The 
nose port placed opposite of the lever’s previous position was designated as the active nose port. 
Pokes in the active port resulted in presentation of the illuminated lever for 2 s on a fixed ratio 
(FR) 1 schedule, and pokes in the inactive port were without consequence. The session lasted for 
40 minutes and the following were recorded using Med Associates software: 1) pokes in the 
active nose port, 2) pokes in the inactive nose port, and 3) contacts with the lever. 
Experiment 2: The Effect of D2/D3 Antagonism by Raclopride on the Expression of Sign- 
and Goal-Tracking Behaviors 
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Male Sprague-Dawley rats (n=60; Charles River Laboratories, Raleigh, NC) weighing 
200-250 g were triple-housed upon arrival. After 7 sessions of autoshaping rats were 
characterized as sign- or goal-trackers based on the average PCA index score from sessions 6 
and 7 as described above. Prior to session 8 all rats received a vehicle injection. A between 
subjects design was the implemented such that rats received injections of vehicle (ST n=6, GT 
n=6) or 0.1 mg/kg raclopride (ST n=9,GT n=7) on sessions 9-12 (see Figure 1a for experimental 
design). This dose was selected as it does not produce locomotor impairment (Chausmer & 
Ettenberg, 1997). All injections were given 30 minutes prior to session start. Animals then 
received one additional injection of vehicle prior to the next session (i.e. session 13) to assess 
possible carry-over effects of treatment. This experimental design allowed for comparing the 
effects of treatment within subjects to their own vehicle performance on session 8, in addition to 
comparing between treatment groups on sessions 9 through 12. 
Experiment 3: The Effect of D3 Antagonism by SB-277011A on the Expression of Sign- and 
Goal-Tracking Behaviors 
Male Sprague-Dawley rats (n=60; Charles River Laboratories, Raleigh, NC) weighing 
150-200 g were pair-housed upon arrival. Following 5 sessions of autoshaping rats were 
characterized as sign- or goal-trackers based on the average PCA index score from sessions 4 
and 5 as described above. Prior to session 6 all rats received a vehicle injection and then, 30 
minutes prior to session 7, rats received either vehicle (ST n=5,GT n=5), 6 mg/kg (ST n=6,GT 
n=7), or 24 mg/kg SB-277011A (ST n=5,GT n=5). See Figure 1b for a summary of the 
experimental design. These doses were selected based on previous preclinical studies and do not 
produce non-specific locomotor effects (Di Ciano, Underwood, Hagan, & Everitt, 2003). This 
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design allowed for comparisons between treatment groups on session 7, in addition to allowing 
comparisons of performance within subjects in each treatment group between sessions 6 and 7.  
Statistical Analyses 
All analyses were performed with SPSS 22.0 (IBM, Armonk, NY). Linear mixed-effects 
models (LMM) were used to assess the effects of treatment on the expression of Pavlovian 
conditioned approach behavior (Verbeke & Molenberghs, 2000).  Session, phenotype, and/or 
treatment group were used as independent variables. The best-fit model of covariance was 
selected by the lowest Akaike information criteria score. Depending on the model selected, 
degrees of freedom were adjusted to a non-integer value. When significant main effects or 
interactions were detected, Bonferroni post-hoc comparisons were made. Performance on the 
conditioned reinforcement test in Experiment 1 was assessed using a three-way analysis of 
variance (ANOVA) in which phenotype (ST vs. GT), treatment (vehicle vs. drug), and nose port 
(active vs. inactive) were the independent variables and the number of pokes was the dependent 
variable. A two-way ANOVA with phenotype and treatment as independent variables and lever 
contacts as the dependent variable was also used to examine group differences on the 
conditioned reinforcement test. Planned comparisons were conducted to assess the effect of 
treatment or nose port within each phenotype. Paired t-tests were used to assess whether 
treatment in Experiment 2 reduced responding relative to initial training stages and whether 
treatment had lasting effects on performance following treatment. For all analyses significance 
levels were set with p≤0.05. 
Results 
Experiment 1: Dopamine D2/D3 Agonism by 7-OH-DPAT Attenuates Both Sign- and Goal-
Tracking Behaviors 
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Acquisition of Pavlovian Conditioned Approach Behavior 
Figure 2 illustrates the differential acquisition of PCA behavior over the initial seven 
sessions of training for Experiment 1. As described above, rats were classified as GTs or STs 
using their PCA index scores, with GTs as those ranging from -1.0 to -0.3, and STs as those with 
scores ranging from 0.3 to 1.0. By the end of this period, STs were reliably approaching (Fig. 2a) 
and manipulating (Fig. 2b) the lever-CS upon its presentation, and did so with increasing rapidity 
(Fig. 2c) over the course of training. In contrast, GTs were reliably approaching (Fig. 2d) and 
entering the food cup (Fig. 2e) upon lever-CS presentation, and did so with increasing rapidity 
(Fig. 2f) over the course of training. Therefore, as seen in previous studies (Flagel et al., 2007; 
Meyer et al., 2012) the lever-CS evoked a conditioned response in both sign- and goal-trackers, 
serving as an equally effective predictor of reward delivery for both groups; yet only for STs did 
the lever-CS attain incentive qualities to the extent that it was attractive and elicited approach. 
Effects of 7-OH-DPAT on Sign- and Goal-tracking Behaviors 
Following the initial 7 training sessions, the effects of 7-OH-DPAT on sign- and goal-
tracking conditioned responses were assessed. Vehicle was administered on alternate days 
between drug injections (see Figure 1a for experimental design) and because there were no 
significant differences in behavior following the repeated vehicle injections, these sessions (i.e. 
sessions 8,9,11,13,15,17,19,20) were averaged and collapsed into a single datapoint per 
phenotype. Dose-response curves were then analyzed with respect to this datapoint (i.e. 0 mg/kg 
in Fig. 3).  
7-OH-DPAT Increases Locomotor Activity 
 Treatment with 7-OH-DPAT impacted the number of food cup entries made by both 
sign- and goal-trackers as indicated by an overall Effect of Dose (F5,19=6.695, p=0.001). 
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Additionally there was an overall Effect of Phenotype (F1,15=5.549, p=0.032). Taken together, 
and as is evident in Figure 7, treatment increased the number of food cup entries during the inter-
trial interval for both sign- and goal-trackers, while goal-trackers made more entries during this 
period overall. 
Sign-Tracking 
Treatment with 7-OH-DPAT attenuated lever-directed behavior for rats classified as STs, 
but not for GTs. There was an overall Effect of Phenotype for the probability to contact the lever 
(F1,38=39.371, p<0.001; Fig. 3a), the number of lever contacts (F1,15=15.649, p=0.001; Fig. 3b) 
and the latency to contact the lever (F1,16=17.857, p=0.001; Fig. 3c).  There was also an overall 
Effect of Dose for each of these measures (lever probability, F5,71=2.902, p=0.019; lever 
contacts, F5,15=8.769, p<0.001; lever latency, F5,71=4.367, p=0.002). As is evident in Figure 3, 
sign-tracking behavior decreased with increasing doses of the drug. Although there was not a 
significant Phenotype X Dose interaction, these effects justified further comparisons. When the 
Effect of Dose was examined for each phenotype separately, there was a significant effect only 
for STs (lever probability, F5,71=4.734, p=0.001; lever contact, F5,15=15.817, p<0.001; lever 
latency, F5,71=7.362, p<0.001). In agreement, post-hoc analysis showed that, relative to 0 mg/kg, 
each dose of 7-OH-DPAT significantly reduced the probability of lever approach (p<0.05), 
decreased the number of contacts (p<0.05), and increased latency to approach the lever (p<0.05) 
and for STs. The latter was true for all doses but 0.32 mg/kg. Taken together, these findings 
demonstrate that 7-OH-DPAT specifically attenuates sign-tracking behavior but appears to have 
a greater effect in those rats with a predisposition to sign-track. 
Goal-Tracking 
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Interestingly, treatment with 7-OH-DPAT attenuated food cup-directed behaviors for rats 
classified as GTs, but not for STs. There was an overall Effect of Phenotype for probability to 
contact the food cup on a given trial (F1,21=271.87, p<0.001; Fig. 3d), the number of food cup 
contacts during the CS period (F1,16=72.143, p<0.001; Fig. 3e), and the latency to approach the 
food cup (F1,18=72.482, p<0.001; Fig. 3f). In addition, there was a significant Effect of Dose for 
each of these measures (food cup probability, F5,62=6.252, p<0.001; food cup contacts, 
F5,23=20.451, p<0.001; food cup latency, F5,75=9.245, p<0.001). There was also a significant 
Phenotype X Dose interaction for each of these measures (food cup probability, F5,62=3.943, 
p=0.004; food cup contacts, F5,23=15.814, p<0.001; food cup latency, F5,75=7.423, p<0.001). As 
illustrated in Figure 3, goal-tracking behavior decreased with increasing doses of 7-OH-DPAT. 
Furthermore, examining each phenotype separately revealed a within-group Effect of Dose for 
all measures in goal-trackers (food cup probability, F5,62=8.252, p<0.001; food cup contacts, 
F5,24=30.684, p<0.001; food cup latency, F5,75=13.874, p<0.001), but not sign-trackers. Thus, 
treatment with 7-OH-DPAT attenuated goal-tracking behavior only in rats predisposed to goal-
track, and not in those predisposed to sign-track. 
7-OH-DPAT Selectively Alters Motivation for Cue Presentation in Sign-Trackers 
Figure 4a illustrates the effects of treatment with 7-OH-DPAT (0.032 mg/kg) on the 
motivation to work for presentation of the lever-CS, or the conditioned reinforcing properties of 
the lever-CS. Although there was not a significant Nose Port x Phenotype x Treatment 
interaction, there was a significant Phenotype x Treatment interaction (F=6.957, p=0.013) and a 
Nose Port X Treatment interaction (F=6.443, p=0.017) that justified further comparisons. As 
shown in Figure 4a, STs treated with vehicle responded to a much greater degree in the active 
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port relative to STs treated with 7-OH-DPAT (p<0.001) and GTs in either treatment group 
(p<0.001).  
Moreover, as expected based on previous studies (Robinson & Flagel, 2009), STs in the 
vehicle group showed a robust preference for the active nose port over the inactive port 
(p<0.001), but in this instance GTs did not (p=0.364). Conversely, STs who received 7-OH-
DPAT did not show a preference for the active over the inactive nose port (p=0.594), in addition 
to poking significantly less in the active port compared to STs in the vehicle group (p<0.001). 
That is, STs that received 7-OH-DPAT were indistinguishable from GTs in either treatment 
group for responding in both the active and inactive ports. There was no effect of treatment with 
7-OH-DPAT on inactive nose pokes for either sign-trackers or goal-trackers. The vigor of 
activity directed towards the lever-CS once it was presented during the conditioned 
reinforcement task was also analyzed. For lever contacts, there was a significant Effect of 
Phenotype (F=10.589, p=0.006) and Treatment (F=7.332, p=0.018), and a trend towards 
significance for a Phenotype X Treatment interaction (F=3.386, p=0.089). Bonferroni post hoc 
analyses revealed that sign-trackers made more contacts with the lever during its brief 
presentation compared to goal-trackers (p=0.006). Although there was no interaction, the effect 
of treatment was examined within each phenotype. Administration of 7-OH-DPAT significantly 
attenuated the number of lever contacts (p=0.006) selectively in sign-trackers as seen in Figure 
4b, and treatment did not alter performance of goal-trackers. Taken together, these data suggest 
that treatment with 7-OH-DPAT selectively impeded the ability of the lever-CS to serve as a 
conditioned reinforcer in sign-trackers, those that attribute incentive salience to the lever-cue.  
Experiment 2: Dopamine D2/D3 Antagonism by Raclopride Attenuates both Sign- and 
Goal-Tracking Behaviors 
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Acquisition of Pavlovian Conditioned Approach Behavior 
 Similar to Experiment 1, following seven autoshaping sessions, animals were 
characterized as sign- or goal-trackers based on the conditioned response that emerged. All rats 
then received a vehicle injection the following day, prior to session 8. For rats assigned to the 
treatment group (ST n=9,GT n=7), raclopride was administered prior to the following four 
sessions (i.e. sessions 9-12) at a dose of 0.1 mg/kg, whereas control rats (ST n=6, GT n=6) 
continued to receive vehicle injections (see Fig. 1a). These five sessions were subjected to 
statistical analyses in order to assess the effect of D2/D3 antagonism on these behaviors. 
Comparisons were made between treated STs and GTs to those not receiving treatment (i.e 
vehicle) over sessions 9 through 12. Additionally, this design allowed for comparisons of 
performance in the treated STs and GTs  over sessions 9 through 12 relative to their response to 
vehicle on session 8 using a within subjects analysis.  
Raclopride Does Not Alter Locomotor Activity 
 As is illustrated in Figure 7, treatment with raclopride failed to alter entries into the food 
cup during the inter-trial intervals, as there was no Effect of Treatment on this measure 
(F1,28=1.470, p=0.236). 
Effect of Raclopride on Sign-Tracking 
  Raclopride treatment impacted the probability of approaching the lever-CS for both 
phenotypes as indicated by an overall Effect of Treatment (F1,26=20.743, p<0.001; Fig 5a). There 
was also a Session X Treatment interaction (F4,60=5.172, p=0.001), and post hoc analyses 
identified an Effect of Session (F4,60=7.582, p<0.001) was restricted to treated rats. This revealed 
that raclopride attenuated treated rats probability of lever approach regardless of phenotype 
across sessions 9 through 12 compared to their probability on session 8.   With respect to 
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contacts with the lever during the CS-period there was a significant Session x Phenotype x 
Treatment interaction (F4,32=3.144 p=0.033; Fig 5b) and post hoc analyses confirmed that 
raclopride attenuated this behavior only in STs as indicated by a within phenotype Effect of 
Treatment (F1,24=12.172 p=0.002), but treatment did not alter lever contacts for GTs. Between 
group comparisons within STs identified lever contacts were only attenuated on sessions 10 
through 12 (p<0.001),. In addition, an Effect of Session within raclopride treated STs 
(F4,24=16.197 p<0.001) indicated those rats were attenuated across sessions 10 through 12 in 
comparison to their vehicle performance on session 8 (p<0.001). Finally, raclopride decreased 
the speed with which treated rats approached the lever-CS as indicated by an overall Effect of 
Treatment (F1,25=18.736, p<0.001). There was also a Session x Phenotype x Treatment 
interaction (F4,60=3.446, p=0.013; Fig 5c) and post hocs identified an Effect of Treatment 
(F1,25=14.187, p=0.001) in STs indicating that on sessions 9-12 treated STs took longer to 
approach the lever-CS compared to vehicle treated STs. Additionally, there was an Effect of 
Session only for raclopride treated STs (F4,60=17.524, p<0.001) indicating each treatment session 
increased the time it took to approach the lever-CS compared to their own performance on 
session 8 (p<0.02) and that the extent of attenuation on sessions 10-12 was greater than on 
session 9 (p<0.001). Interestingly, there was also an Effect of Treatment (F1,25=5.733, p=0.025) 
in GTs indicating that on sessions 11 and 12 raclopride treatment increased latency compared to 
vehicle controls (p<0.04).  
To determine the extent to which raclopride attenuated performance the final session of 
treatment, session 12, was compared to the very first session of autoshaping. Treatment with 
raclopride over four sessions reverted treated sign-trackers to levels equivalent to their 
performance on the very first session across all measures (paired t test, lever probability, t8=-
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0.211, p=0.838; lever contacts, t8=-0.094, p=0.927; lever latency, t8=0.45,p=0.665). Importantly, 
treatment did not have lasting effects on the asymptotic performance of treated sign-trackers, as 
performance off drug on session thirteen did not differ from session eight (paired t test, lever 
probability, t8=0.0, p=1.0; lever contacts, t8=-0.165, p=0.873; lever latency, t8=-0.078, p=0.939). 
These results suggest that D2/D3 antagonism resulted in a decrease in lever-directed behaviors in 
both sign- and goal-trackers, albeit to a greater extent in sign-trackers. 
Effect of Raclopride on Goal-Tracking 
 Raclopride attenuated responding on measures of goal-tracking behavior, but did so only 
in rats previously classified as GTs. There was a significant Treatment x Phenotype interaction 
for both the probability to contact the food cup (F1,24=4.175 p=0.05; Fig 5d) and the number of 
food cup contacts (F1,24=4.410, p=0.046; Fig 5e).  Further, as is evident in Figure 5 and stated 
above, raclopride significantly attenuated responding on these measures for GTs as indicated by 
a within phenotype Effect of Treatment (food cup probability F1,24=7.206 p=0.013; food cup 
contacts F1,24=6.727 p=0.016), but not STs, and the effects were consistent across training 
sessions as there was not an Effect of Session. Finally, raclopride did not alter the time it took to 
approach the food cup following cue presentation as there was not an overall Effect of Treatment 
nor a Treatment x Phenotype interaction (Fig 5f).  This may be due to the fact that goal-trackers 
in this study did not approach the food cup as rapidly as previously observed (Meyer et al., 2012; 
Meyer, Cogan, & Robinson, 2014).  
Additionally, treatment had no carryover effects in those goal-trackers receiving 
raclopride as their performance on session 13, after treatment, was similar to their performance 
on session 8 (paired t-test, food cup probability t6=-1.341, p=0.228; food cup contacts t6=-1.948, 
p =0.099; food cup latency t6=1.295, p=0.243). However, although raclopride was able to reduce 
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food cup-directed behaviors for treated GTs, their performance on the last day of treatement (i.e. 
session 12) was still greater than their performance on session 1 (paired t-test, food cup 
probability t6=-2.567, p=0.043; food cup contacts t6=-2.885, p =0.028; food cup latency t6=3.486, 
p=0.013). Taken together, D2/D3 antagonism produced a consistent within-session attenuation of 
food cup-directed behaviors only in rats classified as goal-trackers, and did not alter these 
behaviors in rats classified as sign-trackers. 
Experiment 3: Selective Antagonism of Dopamine D3 Receptors by SB-277011A Does Not 
Alter Sign- or Goal-Tracking Behaviors 
Linear mixed-effects models revealed that animals acquired a ST or GT conditioned 
response and differed in their propensity to approach the lever or food cup, respectively, across 
sessions as indicated by a Session X Phenotype interaction for all measures (lever probability, 
F6,69=14.432, p<0.001; lever contacts, F6,45=12.932, p<0.001; lever latency, F6,101=11.615, 
p<0.001; food cup probability, F6,59=16.31, p<0.001; food cup contacts, F6,48=19.935, p<0.001; 
food cup latency, F6,62=18,056, p<0.001). However, treatment with either 6 or 24 mg/kg SB-
277011A failed to influence either conditioned response, as there was not an effect of D3 
antagonism on any measure of lever- or food cup-directed behavior (Fig. 6). Additionally, SB-
277011A did not influence locomotor activity, as there was not an Effect of Treatment (Fig. 7). 
Thus, treatment with SB-277011A did not alter performance on any behavioral measures when 
treated sign- and goal-trackers were compared to their vehicle counterparts; nor did SB-277011A 
administration affect performance relative to baseline (i.e. session 6) of rats within treatment 
groups.   
Discussion 
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 It has recently been shown that dopamine, particularly in the core of the nucleus 
accumbens, facilitates the attribution and expression of incentive motivational value, or incentive 
salience, to reward-associated cues (Flagel et al., 2011; Saunders & Robinson, 2012; Saunders, 
O'Donnell, Aurbach, & Robinson, 2014). The present study aimed to build upon these findings 
by examining the contributions of the D2 and D3 receptors in incentive versus predictive 
processes. As in previous studies, it was demonstrated that, following repeated pairings of a 
discrete lever-cue with delivery of food reward in a nearby food cup, two distinct conditioned 
responses develop (Meyer et al., 2012). For some rats, termed sign-trackers, the lever-CS 
acquired characteristics of an incentive stimulus, becoming attractive and reliably eliciting 
approach. In contrast, others developed a goal-tracking response, where the lever-CS served 
solely as a predictor of reward delivery. Following the acquisition of these conditioned 
responses, treatment with the D2/D3 agonist 7-OH-DPAT or the D2/D3 antagonist raclopride 
attenuated the ability of the lever-CS to evoke a conditioned response in both sign- and goal-
trackers. 7-OH-DPAT was also able to abolish the incentive properties of the lever-CS, as it 
attenuated ability of the lever-CS to serve as a conditioned reinforcer for sign-trackers. 
Additionally, treatment with the selective D3 antagonist SB-277011A had no effect on the ability 
of the lever-CS to elicit either of these conditioned responses.  
 It has been argued that treatment with dopamine antagonists results in new learning, and 
produces a gradual reduction in the performance of a learned response (Wise, Spindler, deWit, & 
Gerber, 1978). However, here it was observed that a D2/D3 agonist produced immediate 
detriments in sign- and goal-tracking behaviors. It is also interesting to note that treatment did 
not produce extinction-like effects as deficits occurred on the first day of treatment with 7-OH-
DPAT (A. G. Phillips, McDonald, & Wilkie, 1981). Raclopride, however, produced immediate 
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decrements in goal-tracking behaviors, yet sign-tracking was not attenuated until the second 
treatment session. This would suggest the value of the lever-CS for sign-trackers was not 
immediately being reduced, possibly due to its properties as an incentive stimulus. Although this 
was the case for sign-trackers, treated sign-trackers did not exhibit food cup-directed behaviors 
in response to treatment. This suggests that the value of the CS-US relationship was weakened 
gradually by raclopride in the absence of the learning of a new conditioned response. Moreover, 
performance in these studies returned to measures comparable to baseline performance on the 
session immediately following treatment. These results suggest that treatment with a D2/D3 
agonist or antagonist altered the predictive and incentive value of the CS without updating 
prediction-errors or producing new learning (Shiner et al., 2012). 
 What might then explain why both agonism and antagonism resulted in a similar effect 
on Pavlovian conditioned approach? Interestingly, the D3 receptor is located pre- and post-
synaptically, like the D2 receptor (Joseph et al., 2002). It should also be noted that the D3 
receptor is co-expressed in both D1- and D2-expressing medium spiny neurons in the nucleus 
accumbens (Le Moine & Bloch, 1996) in addition to overlapping expression in most regions 
with the D2 receptor (Diaz et al., 2000; Mansour & Watson, 1995). Thus, both the D2 and D3 
receptors can act to inhibit intracellular signaling post-synaptically and reduce release pre-
synaptically as autoreceptors (Joseph et al., 2002). Theoretically then, administration of an 
antagonist, like raclopride, then would impede dopamine’s ability to bind post-synaptically, but 
would in turn increase levels of dopamine in the synapse through autoreceptor blockade. This 
extra dopamine would possibly then compete with raclopride and ultimately increase dopamine 
signaling post-synaptically. 7-OH-DPAT, on the other hand, would in turn stimulate 
autoreceptors, blunting dopamine release, while producing high levels of post-synaptic activity 
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through agonism in the absence of competition by dopamine. Therefore, it is likely the net 
effects of agonism and antagonism of D2/D3 receptors is paradoxical and results in the same 
effect in stimulating post-synaptic receptors. Alternatively, at synapses where the post-synaptic 
target is the D1 receptor, antagonism of D2/D3 receptors would theoretically increase signaling 
via post-synaptic D1 receptors, while agonism would reduce post-synaptic D1 activation. 
In addition, although the expression patterns of the D2 and D3 receptors mainly overlap, 
particularly in the striatum, it is interesting to note, though, that the D3 receptor is the sole 
dopamine receptor in the paraventricular nucleus of the thalamus, which has been implicated in 
incentive salience attribution (Haight & Flagel, 2014; Mansour & Watson, 1995). Moreover, 
dopaminergic signaling in regions expressing the D2 or D3 receptor may differ in the extent that 
this signaling contributes to differences in the effects of D3 antagonism on food versus drug 
motivated behaviors. Dopamine D3 receptor blockade in the ventral striatum and central 
amygdala are able to inhibit cue-induced cocaine seeking, while microinfusions into the 
basolateral amygdala or dorsal striatum have no effect (Xi et al., 2012). The ventral tegmental 
area, the source of mesocorticolimbic dopamine, also appears to be under control via D3 
mediated signaling, yet no current studies have investigated the role of these receptors in 
behavioral processes (Diaz et al., 2000). Interrogation into the contributions of the D2 and D3 
receptor in specific nuclei may lead to a better understanding of the neural systems underlying 
individual differences in Pavlovian conditioned approach. 
Nevertheless, the findings with the selective D3 antagonist SB-277011A suggest a 
minimal contribution of D3 receptor signaling at a systemic scale to Pavlovian conditioned 
approach to a food-cue. These findings are in line with studies using instrumental and second-
order scales of reinforcement learning under D3 receptor blockade. Preclinical animal models of 
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drug addiction have implicated the D3 receptor in mediating the ability of drugs and drug-cues to 
support self-administration and relapse (Di Ciano et al., 2003). Additionally, in these studies 
employing SB-277011A it has been demonstrated that these attenuations are specific for drugs of 
abuse, and that D3 antagonism does not impact responding for food, or food-cue induced 
responding (Di Ciano et al., 2003; Xi et al., 2012). Thus, it may be that the dopamine D3 receptor 
encodes interoceptive effects of reward, particularly important for drugs of abuse as they produce 
powerful emotional and motivational states that sucrose and grain pellets do not evoke in sated 
animals.  The present study, then, demonstrates for the first time a lack of impact of D3 receptors 
alone on conditioned responding for a food-cue in a purely associative paradigm. Future studies 
should explore the hypothesis that D3 receptor antagonism will impede the ability of a classically 
conditioned opioid or cocaine cue to elicit approach in sign-trackers, but not goal-trackers (Yager 
& Robinson, 2012; Yager, Pitchers, Flagel, & Robinson, 2014). 
The results observed here suggest that dopamine’s actions at the D2, but not D3, receptor 
may be necessary for the proper execution of a conditioned response. However, the doses of 7-
OH-DPAT used in the present studies were selected as they are preferentially selective for D3 
over D2 receptors. 7-OH-DPAT has been shown in vivo to produce yawning behavior, a D3-
mediated behavior, at doses less than 0.1 mg/kg when administered subcutaneously. 
Additionally, the behavioral correlates of D2 stimulation in vivo, hypothermia, are only produced 
by 7-OH-DPAT at doses greater than 0.1 mg/kg (G. T. Collins et al., 2007). Raclopride is a 
pharmacological agent that has almost equal affinities for both the D2 and D3 receptor, so 
interpretations cannot be made as to a possible differential impact at D2 versus D3 receptors 
(Seeman & Van Tol, 1994). Thus, the doses of 7-OH-DPAT used in this study are likely 
preferentially stimulating D3 receptors along with low amounts of agonism at D2 receptors. 
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It is interesting, then, to consider what underlies the unexpected impairment in both sign- 
and goal-tracking following systemic manipulations at the D2/D3 receptors. Systemic 
administration of a non-specific dopamine antagonist, flupenthixol, was also able to attenuate the 
performance of both a sign- and goal-tracking response (Flagel et al., 2011). Interpretations of 
these effects must be taken with caution, however, as locomotor impairment was produced by 
flupenthixol. The findings presented here are interesting in this context, suggesting that the 
findings by Flagel and colleagues may be due to effects primarily at the D2 and D3 receptors. 
Additionally, in the present studies all animals continued to approach and consume all pellets 
throughout treatment and no decreases in locomotor activity were observed, and in the case of 7-
OH-DPAT there was an increase in locomotor activity. However, when administered solely to 
the core of the nucleus accumbens, non-specific dopamine antagonism only impairs the 
expression of a sign-tracking response (Saunders & Robinson, 2012). These results are not in 
conflict with the current findings, as the nucleus accumbens core is simply one target of the 
mesocorticolimbic dopamine system (Fields, Hjelmstad, Margolis, & Nicola, 2007; Salamone & 
Correa, 2012; Wise, 2004), and instead point to circuit-level differences in reward learning 
between sign- and goal-trackers.  
One such possibility is that the D1 receptor contributes to the expression of a conditioned 
response reliant on incentive salience, and that systemic manipulations of D1 signaling may 
differentially impact sign- versus goal-tracking. Dalley and colleagues discovered that D1 
receptors in the nucleus accumbens core were important for the acquisition of a Pavlovian 
conditioned response, yet their contribution is negligible in later stages (Dalley et al., 2005). 
Additionally, Clark and colleagues demonstrated similar results in Pavlovian conditioned 
approach behaviors (Clark, Collins, Sanford, & Phillips, 2013). In accordance with this 
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argument, following a single session, animals exhibiting sign-tracking behavior have enhanced 
D1 mRNA in the core of the nucleus accumbens compared to those exhibiting food cup-directed 
responses, and following additional training this difference in D1 mRNA is lost (Flagel et al., 
2007). Thus, it would be interesting to examine what contributions, if any, dopamine D1 
receptors have to sign- and goal-tracking behaviors.  
Additionally, it should be considered that the experiments presented here occurred 
following the acquisition of each conditioned response. Although dopamine is involved in the 
acquisition of a sign-tracking response (Flagel et al., 2011), it appears that following acquisition 
and during performance of these behaviors dopamine’s actions, especially in the core of the 
nucleus accumbens, are not as important (Clark et al., 2013). This suggests that during so-called 
“automaintenance” conditioned approach no longer relies on dopaminergic signaling (Hursh, 
Navarick, & Fantino, 1974). However, the results here are not in line with this interpretation, and 
instead suggest that for both forms of Pavlovian conditioned approach, signaling at the D2, 
possibly in turn with D3, receptors are required for proper execution of these behaviors. Although 
goal- and sign-trackers differ in D2 mRNA expression in the nucleus accumbens following 
training, it is important to note that for both groups the lever-cue attains predictive value (Flagel 
et al., 2007). The present findings suggest that manipulations at the D2/D3 receptors alter the 
ability of dopamine to signal a predictive CS-US relationship and elicit approach and that 
dopamine signaling in places other than the nucleus accumbens core may be vital for the 
maintenance of conditioned approach. 
In conclusion, these findings are the first to investigate the contributions of D2 and D3 
receptors to Pavlovian conditioned approach behaviors. Following classification as sign- or goal-
trackers systemic manipulations of signaling at the D2 and D3 receptors combined were able to 
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attenuate the previously acquired conditioned response. Moreover, systemic D3 receptor 
antagonism was not able to alter the performance of either conditioned response. Thus, these 
results suggest normal signaling at D2, and to a lesser extent D3, receptors is necessary for proper 
execution of a conditioned response irrespective of incentive salience attribution, and it appears 
that conditioned responding to a food-cue is not reliant on systemic D3 signaling. 
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Fig. 1 Schematic illustration of experimental design. Independent groups of rats were used for 
each experiment. Each numbered box indicates a session of autoshaping. Yellow boxes 
illustrate sessions that experimental compounds were administered prior to session start. 
Grey boxes illustrate sessions where all subjects were administered vehicle. a) Following 7 
sessions of autoshaping rats were classified as sign- or goal-trackers. For Experiment 1 all 
animals underwent treatment according to a within subjects design. Following assessing the 
effects of 7-OH-DPAT rats were split into balanced groups based on their performance in the 
initial 7 sessions and proceeded to undergo a test of conditioned reinforcement. For 
Experiment 2 following classification as sign- or goal-trackers rats were split into balanced 
treatment groups prior to testing with raclopride. b) Following 5 sessions of autoshaping rats 
were classified as sign- or goal-trackers and were split into balanced treatment groups. All 
rats then received vehicle prior to session 6, and then their respective treatment prior to 
session 7. 
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Fig. 2 Individual differences in Pavlovian conditioned approach behavior following autoshaping. 
Lever-directed behavior (sign-tracking; a-c) and food cup-directed behavior (goal-tracking; 
d-f) across 7 sessions of training prior to exposure to 7-OH-DPAT for rats classified as STs 
(n=10) or GTs (n=8). Error bars indicate SEM. 
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Fig. 3 Effects of 7-OH-DPAT on STs (n=10) or GTs (n=8).  Treatment with 7-OH-DPAT 
selectively attenuated the performance of the previous conditioned response, both in sign-
trackers (a-c) and goal-trackers (d-f). Error bars indicate SEM. 
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Fig. 4 Effects of 7-OH-DPAT on Conditioned Reinforcement. Treatment with 7-OH-DPAT 
prevented the acquisition of a new instrumental learning process selectively in sign-trackers. 
Sign-trackers receiving 7-OH-DPAT (n=5) were significantly attenuated compared to 
vehicle controls (n=5) on active nose pokes for lever presentation (a) and vigor of 
responding following lever presentation (b) while goal-trackers were not affected by 
treatment on either measure. *p<0.05 relative to vehicle. Error bars indicate SEM. 
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Fig. 5 Effects of Raclopride on Pavlovian conditioned approach behavior. Following seven 
sessions of autoshaping animals were classified as STs (n=15) or GTs (n=13) based on their 
propensity to approach the lever or food cup during the CS period. On session 8 all animals 
received vehicle injections, then were split into treatment groups with ST (n=6) and GT 
(n=6) receiving only vehicle and the others receiving 0.1 mg/kg raclopride (ST n=9; GT 
n=7) over the next four sessions (shaded region). On session 13 all animals received vehicle 
treatment to reassess behavior following raclopride administration. Raclopride attenuated 
lever-directed behaviors in animals previously classified as STs and GTs (a-c) and food cup-
directed behavior only in animals previously classified as GTs (d-f). Shaded region indicates 
sessions when raclopride was administered. Error bars indicate SEM. 
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Fig. 6 Effects of SB-277011A on Pavlovian conditioned approach behavior. Following five 
sessions of autoshaping animals were classified as STs (n=16) or GTs (n=17). All animals 
received vehicle prior to session six. On session 7 animals received either vehicle (ST 
n=5;GT n=5), 6 mg/kg (ST n=6;GT n=7), or 24 mg/kg (ST n=5;GT n=5) SB-277011A. 
Treatment with SB-277011A did not affect sign-tracking (a-c) or goal-tracking (d-f). Shaded 
region indicates session when SB-277011A was administered. Error bars indicate SEM. 
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Fig. 7 Impact of treatment on non-specific locomotor activity. Treatment with 7-OH-DPAT 
increased locomotor activity as indicated by entries into the food cup during the inter-trial 
intervals for both sign- and goal-trackers as indicated by an Effect of Dose (a). Treatment with 
either raclopride (b) or SB-277011A (c) failed to alter the number of food cup entries during the 
inter-trial interval made by animals that received these agents. Shaded regions represent sessions 
in which treatment was administered for (b) and (c). Error bars indicate SEM. 
 
 
 
